Next-generation Omnipod 6 improves time in range over Omnipod 5 in type 2 diabetes

NEW ORLEANS — Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery system compared with Omnipod 5, according to data from the STRIVE trial. As Healio previously reported, the Omnipod 6 (Insulet) was associated with noninferior time in range, time in hypoglycemia, time in severe hypoglycemia and mean glucose for adults with